Status:
COMPLETED
Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure.
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
Several studies have shown that the PET/CT study with Choline is of great use in the restaging of patients with prostate cancer who present a recurrence of biochemical disease following primary treatm...
Eligibility Criteria
Inclusion
- patients who have been treated with radical prostatectomy;
- patients who present a progressive increase in PSA value during hormonal treatment.
Exclusion
- patients\< 18 years
Key Trial Info
Start Date :
February 4 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 25 2014
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT06168890
Start Date
February 4 2014
End Date
February 25 2014
Last Update
December 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.